Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan

by NASDAQ Market News February 26, 2021

NASDAQ Market News
Click here to email author

The global soy protein ingredients market was valued at USD 8,144.29 million in 2020 and is projected to grow at a CAGR of 2.61% during the forecast period (2021 – 2026)

Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent

Ads